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Available online 24 March 2016Human embryonic stem cells (hESCs) exhibit unique cell cycle structure, self-renewal and pluripotency. The
Forkhead box transcription factor M1 (FOXM1) is critically required for the maintenance of pluripotency in
mouse embryonic stem cells and mouse embryonal carcinoma cells, but its role in hESCs remains unclear.
Here, we show that FOXM1 expression was enriched in undifferentiated hESCs and was regulated in a cell
cycle-dependent manner with peak levels detected at the G2/M phase. Expression of FOXM1 did not correlate
with OCT4 and NANOG during in vitro differentiation of hESCs. Importantly, knockdown of FOXM1 expression
led to aberrant cell cycle distribution with impairment in mitotic progression but showed no profound effect
on the undifferentiated state. Interestingly, FOXM1 depletion sensitized hESCs to oxidative stress. Moreover,
genome-wide analysis of FOXM1 targets by ChIP-seq identiﬁed genes important for M phase including CCNB1
and CDK1, whichwere subsequently conﬁrmed by ChIP and RNA interference analyses. Further peak set compar-
ison against a differentiating hESC line and a cancer cell line revealed a substantial difference in the genomic
binding proﬁle of FOXM1 in hESCs. Taken together, our ﬁndings provide the ﬁrst evidence to support FOXM1
as an important regulator of cell cycle progression and defense against oxidative stress in hESCs.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Pluripotency1. Introduction
Human embryonic stem cells (hESCs) are undifferentiated cells
derived from the inner cell mass of human blastocysts in the pre-
implantation stage (Thomson et al., 1998; Trounson, 2006; Pera and
Tam, 2010). The hESCs are characterized by the capacity to generate
any cell type of all three germ layers (pluripotency) and to grow indef-
initely in an undifferentiated state (self-renewal) (Pera and Tam, 2010;
Young, 2011). They also have a uniquely short cell cycle with an
abbreviated G1 phase (Becker et al., 2006). Thanks to these remarkable
properties, hESCs hold great promise for the development of tissueES cells, embryonic stem cells;
oma cells; EB, embryoid bodies;
ene ontology; RPE, retinal pig-
rowth factor 2; CM, conditioned
edium based on Stemline II
d with BMP4; hFF, human fore-
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hku.hk (K.-M. Yao).
. This is an open access article underreplacement therapy and provide a model system for the study of
early embryonic development and lineage speciﬁcation (Trounson,
2006).
The molecular control of pluripotency and self-renewal in hESCs is
attributed to an interactive network of transcription factors. OCT4,
NANOG and SOX2 are uniquely expressed in pluripotent cells to orches-
trate the transcriptional regulation of pluripotency by collaboratively
activating the transcription of one another, constituting an
autoregulatory circuitry (Boyer et al., 2005; Young, 2011). These three
factors are responsible for driving the expression of genes essential to
pluripotency and self-renewal (Boyer et al., 2005; Young, 2011). Regu-
lation of this complex transcriptional network in stem cells deserves
further analysis to fully understand the molecular basis of the initiation
and maintenance of pluripotency/self-renewal and its pliability.
FOX transcription factors display a vast diversity of biological
functions, including cell proliferation, metabolism, apoptosis and differ-
entiation (Myatt and Lam, 2007). Recent studies revealed the involve-
ment of FOX factors in the regulation of self-renewal and pluripotency
in embryonic stem (ES) cells. In particular, downregulation of FOXD3
in hESCs was shown to disrupt self-renewal and lead to cellthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and Brivanlou, 2012), whereas FOXO1was found to be essential for the
regulation of hESC pluripotency via the direct transcriptional activation
of OCT4 and SOX2 (Zhang et al., 2011).
The proliferation-associated FOX factor FOXM1 plays important
roles in the regulation of cell proliferation, metastasis, apoptosis and
DNA damage repair (Wierstra, 2013b). Studies using various cell
models have shown that FOXM1 is essential for proper cell cycle
progression by regulating the G1/S and G2/M transitions and the
execution of the mitotic program (Laoukili et al., 2005; Wang et al.,
2005; Wonsey and Follettie, 2005; Laoukili et al., 2007). FOXM1
activates the expression of the cell cycle genes CCNB1, CCNB2, CDC25B
and PLK1, which in turn leads to the activation of cyclin-dependent
kinases (CDKs), thereby propelling cells through different cell cycle
phases (Leung et al., 2001; Wang et al., 2002, 2005; Wonsey and
Follettie, 2005).
Recent reports have indicated the functional signiﬁcance of FOXM1
in pluripotent cells. FOXM1 is required for the maintenance of
pluripotency in mouse embryonal carcinoma (EC) cells, via direct
regulation of Oct4 transcription (Xie et al., 2010). More importantly,
FOXM1 is important for maintaining pluripotency in mouse ES cells as
a downstream target of the LIF/STAT3 signaling pathway, thereby
stimulating the expression of pluripotent genes (Tan et al., 2014).
Depleting FOXM1 in mouse ES cells led to a rapid loss of pluripotency
aswell as a decreased rate of cell proliferation (Tan et al., 2014). A recent
study in human EC cells provided evidence that FOXM1 is required for
OCT4 expression, underscoring the potential functional role of FOXM1
in the context of human pluripotent stem cells (Chen et al., 2015).
However, a detailed study of the expression and function of FOXM1 in
hESCs is still lacking.
In this study, we investigated the role of FOXM1 in the regulation of
pluripotency and cell proliferation in hESCs. We demonstrated that
FOXM1 was expressed in undifferentiated hESCs in a cell cycle-
dependent manner, with peak levels reached at the G2/M phase. We
showed that FOXM1 depletion had subtle effects on the undifferentiat-
ed state of hESCs, but led to the downregulation of cell cycle genes and a
delay in G2/M phase progression. Survival of hESCs under oxidative
stress was also compromisedwhen FOXM1was depleted. Interestingly,
genome-wide analysis of FOXM1 binding genomic sequences revealed
FOXM1 targets and putative cooperative factors, which differ
signiﬁcantly from data previously reported in cancer cells. Our results
highlight the important roles played by FOXM1 in maintaining the
proliferation and survival of hESCs.
2. Materials and methods
2.1. Cell culture and differentiation
The human embryonic stem cell line VAL-3, obtained from the
Spanish Stem Cell Bank (Valbuena et al., 2006), was cultured on plates
coated with BD Matrigel™ hESC-qualiﬁed Matrix (BD Biosciences,
USA) in mTeSR™1 Maintenance Medium (STEMCELL Technologies,
Canada) at 37 °C in 5% CO2 (Ludwig et al., 2006). Cell passage was
performed by enzymatic dissociation using Accutase (Invitrogen), and
culture media were supplemented with 10 μM ROCK inhibitor (Y-
27632; Millipore) for the ﬁrst day after cell seeding. Spontaneous
differentiation was initiated by the formation of embryoid bodies (EB)
from VAL-3 cells as previous described (Chen et al., 2012). Details of
EB formation and other in vitro differentiation protocols are described
in the Supplementary material (Extended methods).
2.2. FOXM1 knockdown
FOXM1was depleted by RNA interference (RNAi) using short inter-
fering RNA (siRNA). Cy3-labeled siRNA duplexes, of which two were
against FOXM1 (FOXM1 siRNA #1: 5′-CUC UUC UCC CUC AGA UAU A-3′; FOXM1 siRNA #2: 5′-GGA AAU GCU UGU GAU UCA ACA-3′) and
one was a non-speciﬁc siRNA control (Silencer® Cy3-labeled Negative
Control No.1 siRNA), were purchased from Ambion® (Life Technolo-
gies) as in previous studies (Kong et al., 2013; Liu et al., 2013). Transfec-
tion of cells with siRNAs (25 nM) was performed with Lipofectamine
RNAiMAX (Life Technologies) according to themanufacturer's protocol.
2.3. Quantitative real-time PCR and immunoblot analyses
Real-Time quantitative PCR (qPCR) and immunoblot analyses were
performed with the use of mirVana™ PARIS™ Kit (Ambion®; Life
Technologies) as previously described (Chen et al., 2012). FAM-
labeled primers for genes of interest are listed in Supplementary
Table 1. For details of antibodies and procedures, please see the Supple-
mentary material (Extended methods).
2.4. Immunoﬂuorescence
Cells were ﬁxed with 4% paraformaldehyde (PFA), permeated with
0.1% Triton X-100 in PBST and then blocked with 3% BSA in PBST. After
treatment with mouse anti-FOXM1 (ab55006; 1:100; Abcam), rabbit
anti-OCT4 (H-134; 1:100; Santa Cruz), rabbit anti-phospho-histone
H3 Ser 10 (PH3) (06–570; 1:500; Upstate) or mouse anti-SSEA-1
(MAB4301; 1:128; Millipore), cells were incubated with goat anti-
rabbit IgG Alexa Fluor ® 488, goat anti-rabbit IgG Alexa Fluor ® 568,
goat anti-mouse IgG Alexa Fluor ® 488 or goat anti-mouse IgG Alexa
Fluor ® 568 (Invitrogen). Nuclear counterstaining was performed by
incubation with 1:1000 Hoechst 33258 (Invitrogen), and images were
taken using the confocal microscope LSM 700 (Carl Zeiss). For PH3
staining, the number of cells positive for PH3 was counted in at least
four randomly selected ﬁelds at 100× magniﬁcation, comprising at
least 1000 cells. Cells at different mitotic phases (prophase,
prometaphase, or metaphase/anaphase/telophase) were judged based
on the chromosome staining pattern as previously described
(Neganova et al., 2014).
2.5. Flow cytometric analysis
Cell pellets containing 1 × 106 cells were collected and ﬁxed with
ice-cold 100% methanol. For cell cycle proﬁling, ﬁxed cells were resus-
pended in Flow Staining Buffer containing 1:8333 Hoechst 33258 for
DNA staining prior to ﬂow cytometric analysis. Raw data obtained
were analyzed with Modﬁt TM LT version 4.0 (Verity software). For bi-
variate ﬂow cytometric analysis, ﬁxed cells were blocked in 1% BSA, and
then incubated with 1 μg mouse anti-FOXM1 (Abcam) (in 100 μl).
Isotypic control was prepared by incubating cells with normal mouse
IgG (Millipore) rather than FOXM1 antibody. Cells were then incubated
with goat anti-mouse IgG Alexa Fluor ® 488 (Invitrogen) and
resuspended in propidium iodide (PI) solution (0.5 mg/ml PI, 0.1 g
RNase A, 0.5 g/ml Triton X-100). Cells were subjected toﬂow cytometric
analysis in a BD LSR Fortessa Analyzer (BD Biosciences). Data were
acquired by BD FACSDiva Software (BD Biosciences) and analyzed
with FlowJo version 8.0 (FlowJo, LLC).
2.6. Cell proliferation assay
Cell growth after FOXM1 knockdown and/or hydrogen peroxide
treatment were quantiﬁed by cell counting using the CyQUANT® NF
Cell Proliferation Assay Kit (Life Technologies) according to the
manufacturer's instruction. Details of the assay are given in Supplemen-
tary material (Extended methods).
2.7. ROS assay
To detect the cellular level of reactive oxygen species (ROS), assay
using chloromethyl derivative of 2′,7′-dichlorodihydroﬂuorescein
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manufacturer's instruction. For details, please see Supplementary
material (Extended methods).
2.8. ChIP, ChIP-seq and ChIP–qPCR assays
Chromatin immunoprecipitation (ChIP) assays were performed as
previously described (Bramswig et al., 2013), using FOXM1 antibody
(C20; Santa Cruz) and control IgG (Millipore). Brieﬂy, VAL-3 cells
were treated with 1% paraformaldehyde for chromatin cross-linking
before cell lysis and sonication to generate DNA fragments. Fragmented
chromatin mixed with Dynabeads protein G (Life Technologies) was
incubated with either FOXM1 antibody or rabbit IgG at 4 °C overnight.
Successive rounds of magnetic clearance were performed, followed by
crosslink reversal with NaCl incubation and protein digestion with
proteinase K. DNAwas puriﬁed using theWizard® PCR clean-up system
(Promega). For ChIP-seq, ChIPed DNA and input DNA were ampliﬁed
before library construction, and sequencing was carried out using an
Illumina HiSeq 2000 genome analyzer (by BGI, China). Enrichment of
FOXM1 at speciﬁc promoters was veriﬁed by quantitative PCR using
speciﬁc primers of sequences obtained by personal communication
with Chen et al. (2013). Quantitative PCR was carried out in duplicate
for at least three biological replicates, using SYBR® Select Master Mix
(Life Technologies).
2.9. Computational analysis
Sequence reads obtained from FOXM1 ChIP-seq were aligned
against the hg19 genome (UCSC Genome Browser) using Bowtie2
(Langmead et al., 2009), and peaks were called using MACS (version
2.1.0) (Zhang et al., 2008). Gene annotationwas performed by assigning
peaks to the nearest genes using HOMER (Heinz et al., 2010). Motif
discovery was performed using MEME and DREME (Bailey and Elkan,
1994; Bailey, 2011), and the motifs were matched with known DNA
binding motifs using TOMTOM (Gupta et al., 2007). Gene Ontology
(GO) analyses were performed using DAVID (Huang et al., 2009a;
Huang et al., 2009b).
Peaks of both the OE33 and retinal pigment epithelium (RPE)
datasets (deposited to ArrayExpress under accession number E-MTAB-
4121 and E-MTAB-3137, respectively) were recalled using the same
reference genome (hg19) and same versions of bioinformatics tools.
Our VAL-3 dataset (deposited to the GEO repository at NCBI under ac-
cession number GSE79694) validated by ChIP–qPCR corresponds to a
high coverage dataset. To generate high coverage datasets for both
OE33 and RPE, ChIP and control samples were separately pooled as in-
puts to MACS2 for peak calling. This analysis generates 1268 peaks
and 1221 peaks for OE33 and RPE, respectively, which are comparable
in number to our VAL-3 dataset with 1377 peaks to ensure fair compar-
ison. Peak comparisonwas performedwith the use of Bedtools (Quinlan
and Hall, 2010). Details of statistical analysis are given in Supplementa-
ry material (Extended methods).
3. Results
3.1. FOXM1 is expressed in a cell cycle phase-dependent manner in
undifferentiated hESCs
To unveil its potential role during early human development, we
examined FOXM1 expression in undifferentiated hESCs. FOXM1
expression diminishes in terminally differentiated cells but is markedly
upregulated in various cancer cell lines (Laoukili et al., 2007). Both im-
munoblot and qPCR analyses showed that FOXM1 expression was
enriched in the hESC line VAL-3 (pluripotency reﬂected by OCT4 and
NANOG expression) when compared to human foreskin ﬁbroblasts
(hFFs), which are terminally differentiated (Fig. 1 A and B). FOXM1
expression in hESCs was lower than in HeLa cells (Fig. 1 A and B).Immunoﬂuorescence analysis revealed a predominant nuclear localiza-
tion of FOXM1 in VAL-3 (Fig. 1C) as in mouse ES cells (Tan et al., 2014).
FOXM1 co-localized with the pluripotent marker OCT4 in VAL-3
(Fig. 1C). To examine whether FOXM1 expression in VAL-3 is cell cycle
phase-dependent, we performed bivariate ﬂow cytometric analysis to
correlate FOXM1 levels with DNA content (Fig. 1D). Cells expressed
FOXM1 at all cell cycle phases, but there was an obvious upsurge of
FOXM1when cells entered the G2 andM phases of the cell cycle. Signal
quantiﬁcation indicated 67.0% (P b 0.05) upregulation of FOXM1
expression at G2/M compared to G1 phase and 49.1% (P b 0.05)
upregulation compared to S phase (Fig. 1E).
3.2. FOXM1 expression in differentiated hESCs
To test whether FOXM1 plays a role in the regulation of stem cell
pluripotency, we examined the temporal expression of FOXM1 and the
core pluripotent marker genes OCT4 and NANOG by qPCR during the
spontaneous differentiation of VAL-3 cells at four-day intervals until
24 days of embryoid body (EB) formation. As shown in Fig. 2A, EB
differentiation of hESCs led to a dramatic reduction of OCT4 and
NANOG transcripts (P b 0.01), but there was substantial discrepancy in
FOXM1 mRNA levels among the VAL-3 EB samples collected. FOXM1
levels appeared to ﬂuctuate at all stages of EB differentiation, as indicat-
ed by the large error bars (Fig. 2A).
Retinoic acid (RA) is a potent inducer, driving hESC differentiation
towards a number of speciﬁc lineages in vitro (Gudas and Wagner,
2011; Jagtap et al., 2013). Given that RA-induced differentiation led to
rapid depletion of FOXM1 in mouse EC cells (Xie et al., 2010), it would
be interesting to know whether RA induces a similar effect on hESCs.
VAL-3 cells were induced to differentiatewith 5 μMRA,whereas control
cells were treated with basic ﬁbroblast growth factor 2 (bFGF). VAL-3
colonies subjected to RA treatment underwent dramatic morphological
change indicative of rapid differentiation; increasingly compact cell
clusters emerged from monolayers of adherent cells (Supplementary
Fig. 1). Expression of core pluripotent marker genes diminished
promptly after the initiation of differentiation (Fig. 2B and C). In con-
trast, FOXM1 expression remained high until day 5 and declined starting
fromday 7 (P b 0.05) (Fig. 2D). The efﬁciency of hESC differentiation ini-
tiated by RA was conﬁrmed by elevated levels of differentiation marker
genes in RA-induced hESCs, including PAX6 (ectodermal) and GATA6
(primitive endodermal) (Supplementary Fig. 2).
To gain further insight into FOXM1 expression during differentiation
towards other early lineages,we subjected VAL-3 cells to other differen-
tiation protocols. VAL-3 cells were induced to differentiate towards the
trophectodermal lineage by incubation with BMP4 for nine days (Golos
et al., 2006). We observed signiﬁcant downregulation of FOXM1 tran-
scripts accompanied by the depletion of OCT4 and NANOG mRNAs
(Fig. 2E). However, when VAL-3 cells were induced to endoderm
derivatives using the STEMdiff™Deﬁnitive Endoderm kit, no signiﬁcant
reduction in FOXM1 level was observed after ﬁve days of differentiation,
while OCT4 and NANOG mRNAs decreased dramatically (Fig. 2F).
Similarly, when VAL-3 cells were induced to differentiate towards the
mesodermal lineage upon AVBF induction, no signiﬁcant difference in
FOXM1 expression between samples was found (Fig. 2G), although
OCT4 and NANOG were signiﬁcantly downregulated (data not shown).
Taken together, the lack of direct correlation of expression between
FOXM1 and core pluripotency marker genes during VAL-3 differentia-
tion did not support FOXM1 as an upstream regulator of the core plurip-
otent circuitry in differentiating hESCs. It is interesting to note that
FOXM1 expression is sustained in VAL-3 cells induced to differentiate
into the mesodermal and endodermal lineages.
3.3. FOXM1 knockdown have a subtle effect on hESC undifferentiated state
To investigate the functional role of FOXM1 in undifferentiated
hESCs, we transiently knocked down FOXM1 in hESCs by RNAi. VAL-3
Fig. 1. FOXM1 expression in undifferentiated hESCs. (A–B) Comparing FOXM1 expression in hFF, HeLa and hESC (VAL-3) cells. (A) Immunoblot analysis of cell lysates. (B) Expression of
FOXM1 andNANOG determined by qRNA analysis. n=3. (C) Double immunoﬂuorescence staining of FOXM1 and OCT4 in hESCs. (D–E) Expression of FOXM1 in hESCs across different cell
cycle phases was examined by bivariate ﬂow cytometric analysis. (D) FOXM1-positive cells (above the straight line) were gated as those with FITC intensity higher than the background
(set by the isotypic control). Data shown are representative of four biological replicates. (E) Graphic representation of FOXM1 expression levels at different cell cycle phases. The FOXM1-
positive population was gated into three subpopulations (G1, S and G2/M) based on DNA content. Values are presented as the mean FITC intensity of different subpopulations ± SEM.
*P b 0.05. n= 4.
654 C.T.D. Kwok et al. / Stem Cell Research 16 (2016) 651–661cells were transfected with either FOXM1-targeting siRNAs [#1 or #2
previously validated (Kong et al., 2013; Liu et al., 2013)] or non-
speciﬁc control siRNA. Transfection of FOXM1 siRNA #1 and #2 led to
N70% suppression of FOXM1 mRNA levels compared to control siRNA
at 72 h post-transfection, with siRNA #2 showing stronger suppressive
effect (Fig. 3A). Depletion of FOXM1 at protein level by both FOXM1
siRNAs was veriﬁed by immunoblot analysis (Fig. 3B). The FOXM1
siRNAs used in our knockdown study depleted expression of the A, B
and C isoforms of FOXM1 and the qPCR assay was designed to detect
themRNA expression of all three isoforms. Because FOXM1was report-
ed to be essential for pluripotency in mouse ES cells (Tan et al., 2014),
we ﬁrst examined the effect of FOXM1 knockdown on VAL-3 colony
morphology. Unlike mouse ES cells, FOXM1-depleted VAL-3 cells did
not showmorphological changes suggestive of differentiation. Although
the colonies appeared smaller, cells remained closely packed (Supple-
mentary Fig. 3). Next, we determined the effect of FOXM1 depletion
on the expression of core pluripotent marker genes using qPCR. Despite
a transient reduction ofOCT4 andNANOGmRNA levels after transfection
with FOXM1 siRNA#2 (which showed a stronger suppressive effect) for
two days, expression of OCT4, NANOG and SOX2 stayed high in FOXM1-depleted VAL-3 cells on day 3 and day 4 after transfection (Fig. 3C–E).
Expression of the early differentiation marker gene KRT18 was not in-
duced after FOXM1 knockdown (Fig. 3F). Intriguingly, we observed
the induced expression of differentiationmarker SSEA-1 by immunoﬂu-
orescence in FOXM1-depleted cells (Supplementary Fig. 4). Taken to-
gether, the ﬁndings suggested that transient FOXM1 depletion does
not induce rapid loss of the undifferentiated state of hESCs.
3.4. FOXM1 knockdown impairs hESC proliferation
The smaller colony size of VAL-3 cells upon FOXM1 knockdown
suggested slowdown in hESC proliferation. To address this notion,
VAL-3 cells transfected with FOXM1 siRNA #2 or control siRNA were
monitored for growth using the NF proliferation assay. FOXM1 deple-
tion led to signiﬁcant reduction in cell number on day 4 after transfec-
tion, indicating impaired cell proliferation and/or survival of hESCs
(Fig. 4A). To assess cell cycle kinetics upon FOXM1 knockdown, we
examined the cell cycle proﬁle of transfected VAL-3 cells using ﬂow
cytometric analysis. Interestingly, FOXM1 depletion resulted in an in-
crease in the percentage of cells at G2/M phase (average increase of
Fig. 2. Expression of FOXM1 in hESCs undergoing spontaneous and induced differentiation. Expression of FOXM1 and the pluripotent markers OCT4 and NANOGwas determined by qPCR
analysis and shown as mean ± SEM. (A) Differentiation as embryoid bodies (EBs). **P b 0.01 compared with day 0. n= 4. (B–D) Retinoid acid (RA)-induced differentiation. hESCs were
induced to differentiate by incubating with 5 μMRA, while control cells were incubated with bFGF. Gene expression levels in control samples on day 1 were taken as reference. *P b 0.05,
**P b 0.01when comparedwith bFGF control of corresponding day. n=4. (E–G) Expression of FOXM1,OCT4 andNANOG in differentiated hESCs. hESCs were induced to differentiate using
BMP4 for nine days (E), using deﬁnitive endoderm differentiation (DE) kit reagents for ﬁve days (F), and using AVBF treatment for nine days (G). Control samples were treatedwith bFGF
instead of morphogens. Gene expression levels in control samples on day 1 were taken as reference. ***P b 0.001 when compared with bFGF control of corresponding day. n= 3.
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reduction (Fig. 4B and C). Cell proportion in G1 phase showed no signif-
icant difference (Fig. 4B and C). The sub-G1 population did not increase,
ruling out cell death as the cause of the cell number decrease.
To determine whether the increase in G2/M percentage is due to a
slowdown of mitosis, we assayed the proportion of cells positive for
the phosphorylation of histoneH3 at Ser10 (PH3), an establishedmitot-
ic marker (Hans and Dimitrov, 2001), using immunoﬂuorescence
(Fig. 4D). Importantly, cell counting indicated a signiﬁcant increase in
the percentage of cells positive for PH3 in the FOXM1-depleted group
compared with control (Fig. 4E). After analyzing the number of mitotic
cells in each sub-stage of mitosis (prophase, prometaphase, metaphase/
anaphase/telophase) based on the stainingpattern of chromosomes, the
overall increase in the proportion of PH3 positive cells could be attribut-
ed to the accumulation of cells in prophase and metaphase/anaphase/
telophase (Fig. 4E). Notably, we occasionally observedmisaligned chro-
mosomes along the equator during mitosis in FOXM1-depleted cells
(Fig. 4F), implying defects incurred during chromosomal segregation
at metaphase. Experiments conducted using siRNA #1 gave similar but
weaker cell cycle effects (data not shown). Collectively, our ﬁndingssupport an important role for FOXM1 in the regulation of hESC prolifer-
ation, in particular M phase progression.
3.5. FOXM1 knockdown sensitizes hESCs to oxidative stress
FOXM1 regulates the intracellular levels of reactive oxygen species
(ROS) and protect against oxidative stress through activation of antiox-
idant enzymes in human cells (Park et al., 2009; Halasi et al., 2013). To
investigate the effect of FOXM1 depletion on viability of hESCs under
oxidative stress, VAL-3 cells transfected with control or FOXM1 siRNA
were incubated with hydrogen peroxide (H2O2) at various concentra-
tions for one hour. We observed a signiﬁcant reduction in cell growth
of FOXM1-depleted hESCs, compared with the controls at various
H2O2 concentrations (Fig. 5A). Notably, the difference in cell number be-
tween FOXM1 siRNA- and control siRNA-treated cells increased as H2O2
concentration increased (Fig. 5A), implying that FOXM1 depletion ren-
dered hESCs more vulnerable to growth inhibition by oxidative stress.
To examine the intracellular ROS level in hESCs depleted of FOXM1,
siRNA-transfected VAL-3 cells were loaded with CM-H2DCFDA before
incubation in either normal culture medium or medium containing
Fig. 3.Depletion of FOXM1 in hESCs by RNA interference does not induce sustainable downregulation of pluripotent genes. hESCs, transfectedwith either control siRNA, FOXM1 siRNA #1
or siRNA #2, were analyzed at two to four days post-transfection. qPCR analysis was conducted. Expression data shown as mean ± SEM are relative to control samples at day 2 post-
transfection. (A–B) Temporal expression of FOXM1 in hESCs after siRNA transfection. (A) FOXM1 siRNA #1 and #2 effectively ablated expression of FOXM1 in hESCs. *P b 0.05,
**P b 0.01 when compared with control siRNA sample of corresponding day. n= 4. (B) Immunoblot analysis showing FOXM1 depletion in hESCs after transfection with FOXM1 siRNA
#1 and #2. Data shown are representative of four biological replicates. (C-F) Expression of the pluripotent genes OCT4 (C), NANOG (D), SOX2 (E) and the early differentiation marker
KRT18 (F) was examined by qPCR in hESCs from two to four days post-transfection. *P b 0.05, **P b 0.01 when compared with control siRNA sample of corresponding day. n= 4.
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ROS by ﬂow cytometry. While the intracellular ROS level remained at
comparable levels in samples incubated in normal medium, H2O2 treat-
ment induced a signiﬁcant increase in ROS level in FOXM1-depleted
cells (Fig. 5B), suggesting a role for FOXM1 in suppressing ROS forma-
tion and protecting against oxidative stress. Superoxide dismutase 2
(SOD2) and catalase (CAT), implicated as the dominant antioxidant en-
zymes in hESCs (Cho et al., 2006), were previously reported as tran-
scriptional targets of FOXM1 (Park et al., 2009). To test whether they
are FOXM1 targets in VAL-3 cells, we investigated the expression of
SOD2 and CAT at both the RNA and protein levels after depletion of
FOXM1 expression by both siRNA #1 and #2. Both qPCR and immuno-
blot analyses indicated lowered expression of CAT but not SOD2 uponFOXM1 knockdown (Fig. 5C and D). These data suggest that FOXM1
depletion sensitizes hESCs against oxidative stress, possibly through
downregulation of the anti-oxidant gene CAT.
3.6. Identiﬁcation of FOXM1 target genes in hESCs
To identify FOXM1 target genes in hESCs on a genome-wide scale,
we carried out chromatin immunoprecipitation followed by sequencing
(ChIP-seq) using FOXM1 antibody previously employed in similar stud-
ies. Our results showed that 1377 FOXM1-bound peaks were identiﬁed
using MACS (Zhang et al., 2008), with 45% of the peaks located either
within 1000 bp of transcription start site (TSS) or in the 5′ untranslated
region (UTR) of potential target genes, assigned based on distance
Fig. 4. FOXM1 knockdown in hESCs impairs cell proliferation with delay at the G2/M phase of the cell cycle. (A) Proliferation of hESCs after transfection with control or FOXM1 siRNA #2
was monitored by NF cell proliferation assay for four days. Relative fold change in cell number was expressed with reference to cell number on day 0. Data are shown as mean ± SEM;
*P b 0.05 when compared with control siRNA sample. n = 3. (B) Flow cytometric histograms showing the cell cycle proﬁles of hESCs transfected with control or FOXM1 siRNA #2 at
three days post-transfection. Also shown are the percentages of cells in various cell cycle phases. Data shown are representative of four biological replicates. (C) Quantiﬁcation of cell
cycle distribution revealed an elevated percentage of cells in G2/M phase. Data are shown as mean ± SEM. *P b 0.05 when compared with control siRNA sample. n = 4. (D–F)
Immunoﬂuorescence analysis of the mitotic marker phospho-histone H3 Ser10 (PH3) (green) in hESCs treated with control or FOXM1 siRNA at three days post-transfection. DNA was
stained with Hoechst. Scale bar = 100 μm. (E) Quantiﬁcation of PH3-positive cells and mitotic cells in hESCs treated with control or FOXM1 siRNA at three days post-transfection.
Mitotic cells were regarded as in prophase, prometaphase, or metaphase/anaphase/telophase depending on the chromosome staining pattern. Data are shown as mean ± SEM.
**P b 0.01 when compared to control group. n = 4. (F) Images at higher magniﬁcation. FOXM1 siRNA #2-treated cells displayed defects in mitosis and chromosome alignment at the
equator (enlarged in inset).
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ed by ChIP–qPCR analysis on randomly selected FOXM1 binding loci of
different peak scores, conﬁrming enriched FOXM1 binding to the
putative targets (Supplementary Fig. 5). To establish the biological func-
tions of FOXM1 in relation to transcriptional regulation, we performed
Gene Ontology (GO) enrichment analysis for the potential FOXM1 tar-
get genes (Huang, 2009a; Huang, 2009b) (Fig. 6B). Themost signiﬁcant-
ly enriched GO terms were associated with cell cycle, chromosome
organization and translation. Interestingly, the cluster of enriched GO
terms related to cell cycle predominantly attributed to mitotic progres-
sion, highlighting the importance of FOXM1 in the regulation of cell
cycle progression and mitosis at the transcriptional level.
FOXM1enrichmentwas found in the promoter regions of the known
target genes CCNB1 (Leung et al., 2001) and CDK1 (Chen et al., 2013)
(Fig. 6C). A recent study showed that CDK1 is essential to pluripotency
and cell cycle progression in hESCs (Neganova et al., 2014). ChIP–qPCR
analysis conﬁrmed signiﬁcant enrichment of FOXM1 binding to these
target regions compared to normal IgG control (Fig. 6D). To assess theregulatory function of FOXM1 on these genes, their expression was
assayed by qPCR analysis before and after FOXM1 knockdown using
FOXM1 siRNA #2. Expression of CCNB1 (P b 0.001) and CDK1
(P b 0.05) was signiﬁcantly reduced on day 3 post-transfection
(Fig. 6E). Interestingly, examination of the ChIP-seq binding peaks also
revealed enrichment of FOXM1 binding at the promoter of OCT4 in
undifferentiated VAL-3 cells (Supplementary Fig. 6).
To probe cis elements facilitating FOXM1-chromatin interactions in
hESCs, we performed motif enrichment analysis to look for overrepre-
sented DNA motifs using MEME (Bailey and Elkan, 1994). Their
matching with known motifs using TOMTOM (Gupta et al., 2007)
revealed enrichment of the binding motifs of ZBTB33, TP53 and
PRDM14 (Fig. 6F). While ZBTB33 and TP53 binding motifs were previ-
ously associated with FOXM1 chromatin binding (Choudhary et al.,
2015), it is surprising to see the binding motif of PRDM14, which was
shown to be essential to the regulation of pluripotency in hESCs (Chia
et al., 2010; Chan et al., 2013). Similar motif identiﬁcation results were
obtained using another algorithm DREME. Intriguingly, the canonical
Fig. 5. FOXM1 knockdown sensitizes hESCs to oxidative stress. (A) Growth of hESCs, transfected with control or FOXM1 siRNA #2 and then treated with H2O2 for one hour at various
concentrations, was determined by NF cell proliferation assay. Data are shown as mean ± SEM. *P b 0.05,**P b 0.01 when compared to control sample at the corresponding H2O2
concentration. n= 3. (B) Relative ROS level in hESCs transfected with control or FOXM1 siRNA three days post-transfection. Cells were loaded with CM-H2DCFDA prior to incubation
in mTeSR with or without 100 μM H2O2. Data are shown as mean ± SEM. **P b 0.01 when compared to control sample. n = 3. (C) Expression of CAT and SOD2 transcript levels in
hESCs was analyzed by qPCR upon FOXM1 knockdown at 72 h post-transfection. Data are shown as mean ± SEM. *P b 0.05, **P b 0.01 when compared to control sample. n = 3.
(D) Immunoblot analysis of CAT and SOD2 expression in hESCs transfected with control or FOXM1 siRNAs at 72 h post-transfection. Data shown are representative of three biological
replicates.
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peak set, supporting the notion that chromatin recruitment of FOXM1
in the human genome is mediated mainly via binding to non-
canonical DNA sequences (Sanders et al., 2015).
Most recently, ChIP-seq analysis of FOXM1 binding was conducted
using early differentiating retinal pigment epithelium (RPE) cells
derived from the hESC line SHEF1 (Choudhary et al., 2015), and this
peak set identiﬁes FOXM1 binding sites in the genome of non-
cancerous cells. Importantly, comparing our peak set in undifferentiated
hESCs against the early differentiating RPE dataset revealed extensive
overlap of FOXM1 targets. Out of the 1377 high coverage FOXM1
binding peaks in VAL-3 cells, 498 peaks (36.2%) were commonly
occupied by FOXM1 in RPE cells to give 506 overlapped regions, indicat-
ing a signiﬁcant degree of overlap in chromatin binding proﬁles
(Fig. 6G). In contrast, comparison of FOXM1 binding peaks between
VAL-3 cells and OE33 cells derived from human oesophageal adenocar-
cinoma (Wiseman et al., 2015) showed only 67 shared binding peaks
(4.9%) to give 73 overlapped regions, suggesting a considerable differ-
ence in the chromatin binding proﬁle of FOXM1 between hESCs and
cancer cells (Fig. 6G). It is worth noting that the peak and region num-
bers differ as some peaks in one dataset were found to overlap with
two peaks in another dataset to generate two regions. Representative
views of the peaks that are shared and different between VAL-3 and
RPE/OE33 are shown in Supplementary Fig. 7. Importantly, the well-
established G2/M phase expressed target genes CCNB1 and CENPF arewithin the regions shared by VAL-3 and OE33 (Supplementary
Table 3). However, these regions are not shared by RPE, which was de-
rived from early differentiating hESCs.
4. Discussion
FOXM1 has been extensively studied in cancer cells and during
mouse development and shown to play a role in a broad spectrum of
biological processes. The ﬁrst link of FOXM1 to the regulation of stem
cell pluripotency came with the demonstration that FOXM1 acted
through the core pluripotent circuitry to mediate the maintenance of
pluripotency and self-renewal in mouse pluripotent cells (Xie et al.,
2010; Tan et al., 2014). This notion was further strengthened when
FOXM1 knockdown was shown to downregulate OCT4 expression in
human EC cells (Chen et al., 2015), but the functional relevance of
FOXM1 in hESC remain unclear.
In this study, we showed that FOXM1was highly expressed in undif-
ferentiated hESCs. Similar to other cell types (Korver et al., 1997b; Leung
et al., 2001; Laoukili et al., 2008), FOXM1 displayed periodic expression
during the cell cycle with heightened levels at G2/M. FOXM1 levels did
not decrease precipitously like the core pluripotentmarkers but showed
ﬂuctuations in spontaneously differentiatingVAL-3 cells. Due to the ran-
dom nature of spontaneous differentiation, EBs consist of a mix of cells
committing to various lineages (Pekkanen-Mattila et al., 2010). The
ﬂuctuating expression of FOXM1 during EB differentiation suggests
Fig. 6. Genome-wide analysis of FOXM1 binding in hESCs. (A) Genomic distribution of FOXM1 binding regions in VAL-3 cells. (B) Gene Ontology enrichment analysis of FOXM1 binding
targets. (C) Peaks of FOXM1 binding at the promoters of CCNB1 and CDK1. (D) Preferential association of FOXM1 with CCNB1 and CDK1 promoters. ChIP–qPCR analysis was performed
using primers speciﬁc to the corresponding promoter sequences and the percentage enrichment shown relative to input as mean ± SEM. *P b 0.05 when compared with IgG control.
n= 3. (E) Expression of FOXM1, CCNB1 and CDK1 in hESCs transfected with control or FOXM1 siRNA #2 was analyzed by qPCR at day 3 post-transfection. Data are shown as mean ±
SEM. ***P b 0.001, *P b 0.05 when compared with control siRNA sample. n= 3. (F) Motif enrichment analysis of FOXM1 binding regions identiﬁed motifs recognized by ZBTB33, TP53
and PRDM14. (G) Venn diagram showing the overlap of FOXM1 binding peaks (numbers in purple) to give overlapped binding regions (numbers in white) in VAL-3, RPE and OE33 cells.
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differentiation pathways but does not necessarily correlate with the un-
differentiated state of hESCs. Indeed, in vitro differentiation of VAL-3
cells induced by various morphogens gave different outcomes. While
downregulation was observed in differentiating hESCs upon RA and
BMP4 induction, FOXM1 expression was sustained following differenti-
ation driven by AVBF (mesodermal) and a deﬁnitive endoderm
differentiation kit. The functional requirement of FOXM1 during
differentiation into mesodermal and endodermal derivatives requires
further investigation. Our ﬁndings do not support the direct regulation
of pluripotent genes by FOXM1 during hESC differentiation, in contrast
to previous ﬁndings inmouse and human EC cells (Xie et al., 2010; Chen
et al., 2015).
In linewith the differentiation experiments, siRNA-mediated knock-
down of FOXM1 in hESCs did not induce rapid loss of undifferentiated
state or substantial downregulation of the core pluripotent markers.
Our data differ from the rapid loss of the undifferentiated state anddownregulation of OCT4 and NANOG upon FOXM1 knockdown in
mouse pluripotent cells (Xie et al., 2010; Tan et al., 2014). FOXM1
binds to the OCT4 promoter, stimulating its expression in both mouse
and human EC cells (Xie et al., 2010; Chen et al., 2015). Interestingly,
we did observe subtle and transient downregulation of OCT4 and
NANOG in VAL-3 cells two days after FOXM1 siRNA transfection, as
well as induced expression of SSEA-1, indicating signs of differentiation
upon FOXM1 knockdown. Further, enrichment of FOXM1 binding at the
promoter of OCT4 suggests that FOXM1 might participate in the tran-
scriptional regulation of OCT4. The subtle and transient effect observed
in our study may be due to compensatory regulation upon FOXM1
knockdown. Interestingly, one of the top enriched binding motifs that
coexists with FOXM1 binding is recognized by PRDM14, which was
recently shown to be essential to pluripotency through interactions
with PRC2 to establish repressive histone modiﬁcations and suppress
differentiation genes in hESCs (Chia et al., 2010; Chan et al., 2013).
Potential interactions between FOXM1 and PRDM14 may be speciﬁc
660 C.T.D. Kwok et al. / Stem Cell Research 16 (2016) 651–661to hESCs and highlight a possible link of FOXM1 to pluripotency through
amechanismother than direct transcriptional control of the core plurip-
otent genes.
Based on the differentiation and siRNA studies reported here, the
mechanistic regulation of FOXM1 towards pluripotency control and dif-
ferentiation might differ between mouse and human ES cells. The dis-
crepancy can be attributed to the different developmental status of
human versus mouse ES cells (Nichols and Smith, 2009; Pera and
Tam, 2010). On the other hand, despite being pluripotent the EC cells
have adapted towards tumor growth via suppression of differentiation,
and are distinctly different from ES cells (Sperger et al., 2003; Andrews
et al., 2005). In EC cells there are additional copies of chromosome 12p
(Andrews et al., 2005), where FOXM1 is located (Korver et al., 1997a).
Given that FOXM1 is over-expressed in EC cells (Sperger et al., 2003),
FOXM1 may regulate a different set of biological pathways (see
below), explaining the discrepancy observed.
Human ESCs undergo rapid proliferation with uniquely abbreviated
cell cycles tomaintain self-renewal and pluripotent capacity (Ruiz et al.,
2011; Hindley and Philpott, 2013). The underlyingmolecular regulation
is believed to be distinct from somatic cells (Ruiz et al., 2011; Hindley
and Philpott, 2013). In this study, we demonstrated that FOXM1
knockdown led to impairment of hESC proliferation, mainly due to
delayed progression through the G2/M phase of the cell cycle accompa-
nied by chromosome abnormalities during mitosis. The G2/M delay
with FOXM1 knockdown is consistent with the known function of
FOXM1 reported in other mouse and human cell lines (Laoukili et al.,
2005; Wang et al., 2005;Wonsey and Follettie, 2005). It is also reminis-
cent of the arrest in G2 phase and accumulation of cells in mitosis after
CDK1 knockdown recently reported in hESCs (Neganova et al., 2014).
The critical role of FOXM1 in mitosis in hESCs is supported by the
enrichment of cell cycle genes (in particular M phase relevant genes)
in the GO analysis of the potential FOXM1 target genes discovered in
the ChIP-seq analysis. We conﬁrmed that the known FOXM1 direct
targets CDK1 and CCNB1 are also downstream targets of FOXM1 in
hESCs based on their downregulation upon FOXM1 knockdown and
association of FOXM1 with their promoters. In somatic cells, FOXM1 is
phosphorylated and activated by the CDK1/CCNB1 complex at the S/
G2 phase transition (Chen et al., 2009). FOXM1might also work syner-
gistically with CDK1 and CCNB1 in a positive feedback manner to pro-
mote timely progression through G2/M phase in hESCs. CDK1
depletion showed more obvious effect on hESC pluripotency
(Neganova et al., 2014) than FOXM1 knockdown reported here. This
might be attributed to the incomplete suppression of CDK1 function
upon FOXM1 knockdown and there may also be compensatory regula-
tion of CDK1 upon FOXM1 depletion.
Human ESCs exhibit higher resistance to H2O2-induced stress
compared to their differentiated counterparts (George et al., 2009) by
having an efﬁcient repair capacity with elevated expression of DNA
repair genes (Maynard et al., 2008). Our study supports the involve-
ment of FOXM1 in the defense mechanism of hESCs against oxidative
stress. FOXM1 knockdown impaired recovery of hESCs following H2O2
treatment, as evidenced by elevated ROS level and reduced cell growth,
indicating that FOXM1 depletion renders hESCs more vulnerable to
oxidative stress. FOXM1 depletion was accompanied by downregula-
tion of CAT but not SOD2 at both the RNA and protein levels, supporting
a role for CAT in the defense mechanism. However, no signiﬁcant
binding of FOXM1 to the proximal promoter region of CAT (~10 kb
upstream) was detected by ChIP-seq and ChIP analysis (data not
shown). It remains to be tested whether FOXM1 regulates CAT
transcription by binding to sites far away or whether FOXM1 mediates
its protective effect via other target genes.
The signiﬁcant overlap of potential FOXM1 targets between VAL-3
(reported here) and RPE cells points to a core set of targets regulated
by FOXM1 in non-cancerous cells with healthy genomes. In fact,
ZBTB33 and TP53 are the top two binding motifs coexisting with
FOXM1-bound sequences in both data sets (Choudhary et al., 2015).Unexpectedly, the VAL-3 peak set overlaps with relatively less targets
identiﬁed in the cancer cell line OE33. The overexpression of FOXM1
and thereby the deregulation of downstream targets in various cancer
cells contributes to its principal regulatory role throughout tumorigen-
esis, including tumor initiation, invasion and metastasis (Wierstra,
2013a). The disparate FOXM1 chromatin binding proﬁle may imply
that FOXM1 orchestrates very different sets of downstream targets in
non-cancerous cells versus cancer cells, which are subjected to regula-
tion by very different signaling pathways. Thus, further investigation
is warranted to differentiate the molecular mechanisms underscoring
FOXM1 regulation in normal healthy cells and transformed cells to un-
derstand its regulatory roles in diverse biological processes, which is
of therapeutic relevance for targeting cancer cells.
5. Conclusion
In summary,we provided theﬁrst evidence that FOXM1plays an im-
portant role in themaintenance of cell proliferation in the hESC cell line
VAL-3, with signiﬁcant functions in safe-guarding progression through
G2/M phase mediated by the transcriptional regulation of cell cycle
genes including CCNB1 and CDK1. FOXM1 also protected hESCs against
oxidative stress. Further study of FOXM1 in the context of hESCs will
provide interesting insights into the unique control of abbreviated cell
cycle proliferation and pluripotency in non-cancerous cells, which is
critical for the manipulation and differentiation of hESCs required in
regenerative medicine.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.03.007.
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